Bluestein R H & CO LLC Gsk PLC Transaction History

Bluestein R H & CO LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$42.05 - $47.77 $756,900 - $859,860	-18,000 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $4,022 - $4,774	-100 Reduced 0.55%	18,000 $784,000
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $77,760 - $90,620	-2,000 Reduced 9.95%	18,100 $798,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $193,950 - $215,799	5,000 Added 33.11%	20,100 $768,000
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $3,652 - $4,146	-100 Reduced 0.66%	15,100 $601,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $64,733 - $75,886	-1,900 Reduced 11.11%	15,200 $559,000
Q2 2020 Aug 12, 2020	BUY	$37.87 - $43.58 $3,786 - $4,358	100 Added 0.59%	17,100 $698,000
Q1 2020 May 12, 2020	BUY	$32.47 - $48.83 $64,940 - $97,660	2,000 Added 13.33%	17,000 $644,000
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $353,400 - $419,000	-10,000 Reduced 40.0%	15,000 $532,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $986,000 - $1.04 Million	25,000	25,000 $1.02 Million

167K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Bluestein R H & CO LLC with notifications on news.